Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xhesika Shanja-Grabarz"'
Autor:
Nicholas James Favazza, Yossef Rubinov, Alexis V Benjamin, Xhesika Shanja-Grabarz, Gary Deutsch
Publikováno v:
Journal of the American College of Surgeons. 236:S104-S105
Autor:
Haejin In, Xhesika Shanja-Grabarz, Manasa Kanneganti, John C. McAuliffe, Rebecca Levine, Patricia Friedmann, Renee Huang
Publikováno v:
J Gastrointest Surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56697549eec181b14bab152e5a601821
https://europepmc.org/articles/PMC8368069/
https://europepmc.org/articles/PMC8368069/
Publikováno v:
Endocr Relat Cancer
Genetically engineered and orthotopic xenograft mouse models have been instrumental for increasing our understanding of thyroid cancer progression and for the development of novel therapeutic approaches in a setting that is more physiologically relev
Publikováno v:
International Journal of Surgery. 83:271
Publikováno v:
Cancer Research. 80:1801-1801
Despite advancements in cancer therapy, anaplastic thyroid cancer (ATC) remains a lethal disease. In fact, the effect of both current chemoradiation regimens and of investigative targeted therapies is at best cytostatic, as shown by the systematic la
Autor:
Lisa Santoriello, Gene F. Coppa, Jeffrey Nicastro, Rafael Barrera, Xhesika Shanja-Grabarz, Gary Ritter, Vihas Patel
Publikováno v:
International Journal of Surgery: Global Health. 3:e14-e14
Autor:
Francesca Di Cristofano, Antonio Di Cristofano, Xhesika Shanja-Grabarz, Evripidis Gavathiotis
Publikováno v:
Cancer Research. 79:LB-089
Despite recent advancements in chemotherapy and radiation, anaplastic thyroid cancer (ATC) remains an almost invariably lethal disease with an average life expectancy of 2-6 months. Current interventions, including surgery are palliative, underlining